BCM
ALAB icon

Brookstone Capital Management’s Astera Labs ALAB Stock Holding History

Brookstone Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
+2,850
New +$756K 0.01% 607

Other funds holding ALAB

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
TEC
Tensor Edge Capital Weston, Massachusetts $1.51B AUM
MLCM
M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Brookstone Capital Management's ALAB Position: Q2 2026 in Review

Brookstone Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 2,850 shares worth $1.38M. The stake represents 0.01% of the portfolio and ranks #607 among its holdings.

201 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Brookstone Capital Management held 2,850 shares of Astera Labs worth $1.38M as of Q2 2026.
  • Astera Labs was a new Brookstone Capital Management position in Q2 2026.
  • Astera Labs made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #607 holding.
  • 201 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.